Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
By A. Klein, K. Brune, G. Petersen, M. Goggins, A. C. Tersmette, G. Offerhaus, C. Griffin, J. Cameron, C. Yeo, S. Kern and 1 more. Cancer Research, 2004
653 citations recorded by the source corpus.
Subfields: Epidemiology, Oncology, Surgery
View Paper: https://www.semanticscholar.org/paper/4c02e6544ba9564375dd2de13ef7ee2dddf1af1e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Oncology
In Surgery
Citations in the corpus
- Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer (2009, background): “In addition, it has been estimated that a small proportion of pancreatic cancers are due to highly penetrant germline mutation”
- Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. (2017, background): “The risk of an individual of developing PDAC based on family history alone has been well established [233,234].”
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. (2012, background): “The risk of an individual developing PDAC based on family history alone has been well established [184,185].”
- International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer (2012, background): “57 However, follow-up imaging was recommended less than 6 months after surgery if there was any PanIN-3 in the resected pancreas of individuals without PC.”
- Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors (2019, background): “Prospective analysis of families with this malignant disease shows that first-degree relatives of individuals with familial pancreatic cancer have a nine-fold increased risk of pancreatic cancer over the general population [4].”